Find out which of these stocks fell the most.
News & Analysis: Achaogen
The FDA gave the company a green light for one indication, but it rejected the use of its antibiotic in another.
Key events will make May a month to remember or forget for these fledgling drugmakers.
A small, but potentially important, milestone was achieved.
Despite a strong market, these stocks fell. Find out why.
Growth investors can start off the year by taking a deeper look into these three promising healthcare stocks.